March 03, 2026

Jose R. Soler, M.D., FACC, Joins Baptist Health Heart & Vascular Care

Board-certified cardiologist Jose R. Soler, M.D., has joined Baptist Health Miami Cardiac & Vascular Institute, part of Baptist Health Heart & Vascular Care.

Baptist Health South Florida

March 02, 2026

Frailty Linked to Higher Mortality Risk in Men Than Women After Heart Attack

National study of more than 900,000 patients finds frailty more prevalent in women but more strongly associated with death in men, highlighting a “sex-frailty paradox” in outcomes.

Conexiant

February 27, 2026

Shared Decision-Making Is Institution-Driven 

National registry analysis finds institutional factors outweigh patient characteristics 

Conexiant

February 26, 2026

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

Conexiant

March 04, 2026

Low-Dose Rivaroxaban Did Not Reduce LV Thrombus After Anterior STEMI

Adding low-dose rivaroxaban to dual antiplatelet therapy following anterior myocardial infarction did not reduce cardiac MRI–detected left ventricular thrombus at 1 month and increased minor bleeding in a 560-patient randomized trial.

Conexiant

February 25, 2026

AI May Help Close Women's Health Gap

Endometriosis was cited to illustrate challenges, with definitive diagnosis estimated to take an average of 7 to 10 years.

Conexiant

February 24, 2026

A Minimally Invasive Approach to Complete LAD Occlusion

"The LAD is the artery that runs on the surface of your heart and supplies blood to about a third of the muscle mass of the heart. If that artery becomes totally blocked, a large portion of the heart has little to no blood flow.”

Baptist Health South Florida

February 24, 2026

Can MRI Predict Perforator Stroke Progression?

Investigators evaluate multisequence imaging for its ability to identify patients at risk for neurologic progression.

Conexiant

February 23, 2026

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Conexiant

February 23, 2026

Lifestyle Interventions vs Gestational Diabetes

Investigators report that lifestyle interventions during pregnancy reduce gestational diabetes risk, with effects varying by diagnostic criteria and maternal education level.

Conexiant